Arrayit Corporation (ARYC)

[rokkdatstock]

How we got here UNITED STATES OF AMERICA
Before the
SECURITIES AND EXCHANGE COMMISSION
April 13, 2020
In the Matter of Arrayit Corporation File No. 500-1
ORDER OF SUSPENSION OF TRADING
It appears to the Securities and Exchange Commission that the public interest and the protection of investors require a suspension in the trading of the securities of Arrayit Corporation (“ARYC” or “the Company”) (CIK No. 0001084507) because of questions regarding the accuracy and adequacy of publicly-available information concerning Arrayit Corporation, including: (a) its financial condition and its operations, if any, in light of the absence of any public disclosure by the Company since 2015, and (b) information in the marketplace since at least March 2, 2020, claiming the Company developed an approved COVID-19 blood test. Arrayit Corporation is a Nevada corporation with its principal place of business located in Sunnyvale, California. The Company’s common stock is quoted on OTC Link LLC (previously Pink Sheets), operated by OTC Markets Group Inc., under the symbol ARYC. As of April 7, 2020, ARYC’s common stock had seven market makers, and was eligible for the “piggyback” exception of Rule 15c2-11(f)(3) under the Securities Exchange Act of 1934.
The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company.
THEREFORE, IT IS ORDERED, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EDT on April 14, 2020, through 11:59 p.m. EDT on April 27, 2020.
By the Commission.
2
Vanessa A. Countryman Secretary